News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Innovative mHealth Devices Enable Smartphone Users to Self-Test and Share Results in Real Time

New mHealth devices open the door for clinical laboratories and pathologists to offer continuous monitoring services to patients which incorporate the patient’s self-test results with that patient’s cumulative medical lab test data

In today’s age of mobile computing, healthcare applications are hot. Now comes news that a Swiss company has launched what it calls the world’s first medical smartphone! Of note to clinical laboratory managers and pathologists is the fact that this medical smartphone is designed to capture and analyze several health measures that are often the subject of medical laboratory clinical laboratory tests, including blood gases and blood glucose.

This medical smartphone is manufactured by LifeWatch AG (LIFE:SW), based in Neuhausen am Rheinfall, Switzerland. The LifeWatch V lets users self-test their health.

“The…smartphone allows [users] to self-operate a wide range of highly valuable embedded medical sensors, wellness-related applications, cloud-based services, and 24/7 call center support,” the company stated in a news release. The device operates on an Android operating system. (more…)

DarkDaily.com Weekly E-Briefing Recap – Week Ending April 20th, 2012

Here’s what you may have missed this week in the clinical lab world. It was a busy week…

Chronic Disease Management Program in New York City Uses EHRs to Help Physicians Improve Patient Care

Published: April 20 2012

As part of NYC’s PCIP, physicians utilize clinical laboratory testing more effectively to diagnose disease and monitor patients

Seven years into a targeted program to use clinical data to drive measurable improvement in the health of patients with chronic diseases, health officials in New York City are declaring the effort to be successful at meeting several important goals. Some healthcare experts say NYC’s innovative project provides valid insight into the future of American healthcare.
(more…)

Aetna, Humana, Kaiser, UnitedHealth Put Five Billion Medical Claims into Database for Healthcare Cost, Utilization Research

Data represents $1 trillion in spending since 2000 and contains clinical laboratory and pathology data

In what may turn out to be a positive development for clinical laboratories and pathology group practices, four of the nation’s five biggest health insurance companies will collaborate and put their medical claims data for billions of transactions into a single data base. Researchers say this database will give them an unprecedented ability to assess utilization trends and the clinical care delivered to patients covered by private health insurance.

The four health insurance companies that will provide data are:

The data provided by each of these health insurers will be submitted to the newly-created Health Care Cost Institute (HCCI). This data will consist of more than five billion medical claims dating back to 2000. These claims represent more than $1 trillion in spending. The health insurers are also providing the financing required to launch HCCI. (more…)

Pathology Groups and Clinical Laboratories Should Prepare for Medicare RAC Auditors

2011 is the year that Medicare expands its Recovery Audit Program to include providers such as medical laboratories and pathology groups

During the next 12 months, many pathology groups and clinical laboratories will undergo their first audit as part of Medicare’s recently-expanded RAC (Recovery Audit Contractor) program. This is a big-dollar audit program. When Congress passed the enabling legislation, it was estimated that RAC would generate $10 billion in recoveries from hospitals, physicians, medical laboratories and other providers.
(more…)

UPMC to Use Digital Pathology Imaging to Provide Anatomic Pathology Consulting Services to China

Second-opinion consults will be handled by UPMC’s sub-specialist pathologists


Here’s a unique anatomic pathology collaboration that crosses international borders and will utilize state-of-the-art digital pathology technology to support subspecialty pathologist consultations between the United States and China.

In recent weeks, the University of Pittsburgh Medical Center (UPMC) disclosed that it will provide a range of healthcare services to what is only described as “the largest pathology laboratory in Shanghai.” Of particular interest to pathologists and clinical laboratory managers in the United States, is the fact that pathologists at UPMC will provide second opinion anatomic pathology services to this as-yet-unnamed Chinese pathology laboratory.

(more…)

;